Dr Yacoob A.K. Vahed

Principal Investigator | Welkom Clinical Trial Centre Welkom, Free State, South Africa Dr Yacoob A.K. Vahed is an experienced medical doctor and Principal Investigator at Welkom Clinical Trial Centre, based in Welkom, Free State, South Africa. With more than 30 years of experience in clinical medicine and over 18 years in clinical research, Dr Vahed brings extensive expertise in the conduct of international clinical trials and a strong commitment to advancing patient-centred healthcare. Dr Vahed obtained his medical degree (MBBCh) from the University of the Witwatersrand in 1993, following a Bachelor of Science from the University of KwaZulu-Natal and an Honours degree from the University of Cape Town. He has practised as a general medical practitioner since 1995 and has been actively involved in clinical research since 2008. Throughout his research career, Dr Vahed has served as Principal Investigator on numerous Phase II and Phase III clinical trials across a broad range of therapeutic areas, including asthma, chronic obstructive pulmonary disease (COPD), diabetes, influenza, respiratory syncytial virus (RSV), COVID-19, dermatology and osteoarthritis. His extensive research portfolio includes paediatric and adult respiratory studies, vaccine development programmes and investigations into emerging treatments for infectious and chronic diseases. His experience across diverse patient populations and complex study protocols provides a strong foundation for delivering high-quality clinical research. Through Welkom Clinical Trial Centre, Dr Vahed continues to contribute to international clinical research, combining his longstanding medical experience with a commitment to ethical research conduct, participant safety and the generation of reliable clinical data. As part of the broader clinical research consortium, Dr Vahed brings established investigator expertise, diverse therapeutic experience and valuable research capacity in the Free State, strengthening South Africa's ability to participate in global clinical trials.